Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18909568 | METHODS OF PREPARING A POSTBIOTIC COMPOSITION | October 2024 | January 2026 | Allow | 15 | 5 | 0 | Yes | No |
| 18894709 | Compositions and Methods for Making Epigenetic Modifications | September 2024 | March 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18750621 | High Fidelity Restriction Endonucleases | June 2024 | October 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18740177 | SYSTEM AND METHOD FOR PRESERVING ALGAE | June 2024 | September 2025 | Abandon | 15 | 2 | 0 | Yes | No |
| 18444590 | Compositions and Methods for Making Epigenetic Modifications | February 2024 | June 2024 | Allow | 4 | 0 | 0 | Yes | No |
| 18405861 | PROTEASE VARIANTS AND USES THEREOF | January 2024 | July 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18561170 | IDENTIFICATION OF AN alpha-1,2-FUCOSYLTRANSFERASE FOR THE IN VIVO PRODUCTION OF PURE LNFP-I | November 2023 | June 2025 | Allow | 19 | 1 | 1 | Yes | No |
| 18121697 | Modified Yeast Microorganisms to Increase Yield of 3-Hydropropionic Acid | March 2023 | October 2024 | Allow | 19 | 1 | 1 | Yes | No |
| 18022140 | METHODS AND COMPOSITIONS FOR PURIFICATION OF TRIMERIC FUSION PROTEINS | February 2023 | December 2025 | Allow | 34 | 1 | 0 | No | No |
| 18082128 | STABLE LIPASE FORMULATIONS AND METHODS THEREOF | December 2022 | March 2025 | Abandon | 27 | 2 | 0 | No | No |
| 18078159 | Methods for enzymatic production of glucosamine salts and the purification methods thereof | December 2022 | March 2026 | Abandon | 39 | 2 | 0 | No | No |
| 17914914 | COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC ENZYME REPLACEMENT THERAPY | September 2022 | February 2026 | Abandon | 40 | 1 | 1 | No | No |
| 17934765 | METHOD | September 2022 | August 2025 | Abandon | 35 | 3 | 0 | No | No |
| 17912111 | BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE | September 2022 | October 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17895320 | ENGINEERED SPIDER SILK PROTEINS AND USES THEREOF | August 2022 | February 2026 | Allow | 41 | 1 | 0 | No | No |
| 17836735 | Treatment Of Psoriasis With Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors | June 2022 | November 2025 | Allow | 41 | 2 | 0 | No | No |
| 17781124 | GENE ENGINEERING BACTERIA FOR PRODUCING L-ARGININE AND CONSTRUCTION METHOD AND APPLICATION OF GENE ENGINEERING BACTERIA | May 2022 | November 2025 | Allow | 42 | 1 | 1 | Yes | No |
| 17747589 | CELL BASED SHEAR STRESS SENSOR | May 2022 | October 2025 | Allow | 41 | 2 | 1 | Yes | No |
| 17744646 | ENDOPHYTIC FUNGUS PSEUDOPHIALOPHORA ORYZAE P-B313 AND ITS APPLICATION | May 2022 | October 2024 | Allow | 29 | 2 | 0 | No | No |
| 17729752 | METHOD OF INDUCING EXPRESSION OF CALCIUM CHANNEL AND/OR CALCIUM PUMP, AND APPARATUS THEREFOR | April 2022 | December 2025 | Allow | 44 | 2 | 1 | Yes | No |
| 17699354 | T4 DNA Ligase Variants with Increased Ligation Efficiency | March 2022 | July 2025 | Allow | 40 | 8 | 0 | Yes | No |
| 17642874 | PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF PROTEIN/PROTEIN-FUSIONS | March 2022 | June 2025 | Allow | 39 | 1 | 1 | Yes | No |
| 17637443 | FOLATE PRODUCING STRAIN AND THE PREPARATION AND APPLICATION THEREOF | February 2022 | October 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17675556 | Gene Editing Nanocapsule and Preparation Method and Use Thereof | February 2022 | May 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17590774 | RECOMBINANT MILK PROTEINS AND FOOD COMPOSITIONS COMPRISING THE SAME | February 2022 | May 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17630627 | METHOD FOR PURIFYING ANTIBODY USING ADSORBENT | January 2022 | April 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17630579 | PROTEIN HAVING ACTIVITY OF CATALYZING alpha-1, 6 GLUCOSYL TRANSFER REACTION | January 2022 | March 2026 | Abandon | 50 | 2 | 1 | Yes | No |
| 17578681 | METHODS OF IMPROVING PROTEIN TITER IN CELL CULTURE | January 2022 | February 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17628451 | METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS | January 2022 | October 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17623231 | VARIANT DIHYDRODIPICOLINATE REDUCTASE POLYPEPTIDE AND METHOD OF PRODUCING L-THREONINE USING THE SAME | December 2021 | July 2025 | Allow | 43 | 1 | 1 | Yes | No |
| 17622068 | NOVEL LACTOBACILLUS PLANTARUM, LACTIC ACID BACTERIA COMPOSITION AND USE THEREOF FOR CURING OR PREVENTING HEAVY METAL RELATED DISEASES | December 2021 | January 2026 | Abandon | 49 | 2 | 1 | No | No |
| 17620990 | METHOD FOR PRODUCING EXOSOMES BY ELECTRICAL STIMULATION | December 2021 | June 2025 | Abandon | 42 | 1 | 1 | No | No |
| 17555684 | SYSTEMS AND METHODS FOR REMOVING METHANE FROM A GAS STREAM | December 2021 | September 2024 | Abandon | 33 | 2 | 0 | Yes | No |
| 17554164 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | December 2021 | January 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17620324 | Co-Culture of Myxobacteria and Pseudomonas for Enhanced Production of Biosurfactants and Other Metabolites | December 2021 | December 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17615512 | PROBIOTIC COMPOSITIONS AND METHODS OF USE | November 2021 | June 2025 | Abandon | 42 | 2 | 1 | No | No |
| 17615256 | Metabolomic Characterization of Microorganisms | November 2021 | January 2025 | Allow | 37 | 3 | 0 | Yes | No |
| 17613147 | Detection of Glycosaminoglycans | November 2021 | January 2026 | Abandon | 50 | 2 | 1 | No | No |
| 17612870 | TREATMENT OF SENSORINEURAL DEAFNESS | November 2021 | November 2025 | Abandon | 48 | 3 | 0 | Yes | No |
| 17610250 | TARGETING SEQUENCES FOR PAENIBACILLUS-BASED ENDOSPORE DISPLAY PLATFORM | November 2021 | November 2024 | Abandon | 36 | 1 | 1 | No | No |
| 17609746 | COMPOSITION FOR PREVENTING OR TREATING OBESITY, COMPRISING PHOSPHOLIPASE A2 AS ACTIVE INGREDIENT | November 2021 | March 2026 | Abandon | 52 | 3 | 0 | No | No |
| 17493100 | RECOMBINANT MILK PROTEINS | October 2021 | June 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17490486 | METHOD OF MANIPULATING PHAGES WITHIN THE BODY TO ATTACK INFECTIOUS TARGET CELLS | September 2021 | November 2025 | Abandon | 50 | 3 | 0 | Yes | No |
| 17441888 | Compositions and Methods for Modifying Dystrophin Genes | September 2021 | November 2024 | Abandon | 38 | 0 | 1 | No | No |
| 17440973 | WASTE TREATMENT SYSTEM AND WASTE TREATMENT METHOD | September 2021 | October 2025 | Abandon | 49 | 3 | 1 | Yes | No |
| 17437114 | POLYPEPTIDE VARIANTS | September 2021 | November 2024 | Allow | 38 | 1 | 1 | No | No |
| 17394184 | MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION | August 2021 | December 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17427764 | Lactobacillus Mudanjiangensis Strains And Cellulase Derived Therefrom | August 2021 | January 2025 | Allow | 41 | 2 | 0 | No | No |
| 17423262 | METHOD FOR PRODUCING L-AMINO ACIDS USING MICROORGANISM CONTAINING NADP-DEPENDENT GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE | July 2021 | July 2024 | Allow | 36 | 2 | 0 | Yes | No |
| 17366239 | EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS | July 2021 | May 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17364632 | LACTOBACILLUS PARACASEI AND USES THEREOF | June 2021 | May 2024 | Allow | 35 | 2 | 0 | Yes | No |
| 17416928 | DNA-BARCODED NUCLEOSOMES FOR CHROMATIN MAPPING ASSAYS | June 2021 | July 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17351422 | FLUORESCENT ASSAY SYSTEMS FOR REAL-TIME MEASUREMENT OF PROTEIN UBIQUITINATION AND USES THEREOF | June 2021 | October 2025 | Abandon | 52 | 3 | 1 | No | No |
| 17415600 | SLIDING CLAMP-BASED AFFINITY PURIFICATION SYSTEMS, METHODS OF MAKING AND USE THEREOF | June 2021 | November 2025 | Allow | 53 | 2 | 1 | Yes | No |
| 17414604 | MALONIC SEMI-ALDEHYDE-PRODUCING YEASTS | June 2021 | September 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17309629 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | June 2021 | June 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17337201 | METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID | June 2021 | July 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17296932 | Improved Filamentous Fungal Host Cells | May 2021 | June 2025 | Allow | 48 | 1 | 1 | No | No |
| 17296622 | TRANSMEMBRANE DOMAIN DERIVED FROM HUMAN LRRC24 PROTEIN | May 2021 | November 2024 | Allow | 42 | 2 | 1 | No | No |
| 17295400 | PURIFICATION OF IDURONATE-2-SULFATASE IMMUNOGLOBULIN FUSION PROTEIN | May 2021 | June 2025 | Abandon | 49 | 3 | 0 | No | No |
| 17294287 | G-TO-T BASE EDITORS AND USES THEREOF | May 2021 | May 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17289665 | NUCLEOBASE EDITORS COMPRISING GEOCAS9 AND USES THEREOF | April 2021 | November 2024 | Allow | 43 | 1 | 1 | Yes | No |
| 17287135 | AN ANTIMICROBIAL COMPOSITION FOR SELECTIVELY INHIBITING GROWTH OF P. ACNES BACTERIA | April 2021 | May 2025 | Abandon | 48 | 2 | 0 | Yes | No |
| 17227799 | High Fidelity Restriction Endonucleases | April 2021 | April 2024 | Allow | 36 | 1 | 0 | No | No |
| 17226693 | High Fidelity Restriction Endonucleases | April 2021 | April 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17272315 | PROCESS FOR BIOLOGICAL AMMONIA PRODUCTION BY NITROGEN FIXING CYANOBACTERIA | February 2021 | October 2025 | Abandon | 55 | 2 | 0 | No | No |
| 17178805 | EVALUATING METHOD OF KETOSIS IN POSTPARTUM DAIRY COWS | February 2021 | December 2024 | Allow | 46 | 3 | 0 | Yes | No |
| 17262350 | Artificial Hair Fiber, Method for Manufacturing Same, and Artificial Hair | January 2021 | July 2025 | Abandon | 54 | 3 | 1 | Yes | No |
| 17260984 | GENERATION OF ACYL AMINO ACIDS | January 2021 | June 2024 | Allow | 41 | 2 | 0 | Yes | No |
| 17260483 | MEANS AND METHOD FOR THE REAL-TIME ANALYSIS OF HARVESTED CROPS | January 2021 | January 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17259147 | RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF | January 2021 | August 2025 | Allow | 55 | 4 | 0 | Yes | No |
| 17258088 | MICROBIAL METHOD FOR PRODUCTION OF PROTEIN ISOLATE/CONCENTRATE FROM OILSEED CAKES/MEALS | January 2021 | January 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17082876 | USE OF COMPOSITIONS OF WATER/ALCOHOL EXTRACTS OF ANTRODIA CINNAMOMEA CUT-LOG WOOD CULTIVATED FRUITING BODY AND SOLID-STATE CULTIVATED MYCELIUM AS AUXILIARIES FOR ANTI-CANCER AGENTS | October 2020 | April 2025 | Abandon | 54 | 4 | 0 | Yes | No |
| 16947959 | ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF | August 2020 | April 2024 | Abandon | 43 | 2 | 1 | Yes | No |
| 16768055 | SynP61, A PRIMATE RETINAL PIGMENT EPITHELIUM CELL-SPECIFIC PROMOTER | May 2020 | June 2024 | Abandon | 48 | 1 | 0 | No | No |
| 16639719 | USE OF ANTI-CRISPR POLYPEPTIDES FOR SPECIFIC ACTIVATION OF CAS NUCLEASES | February 2020 | December 2024 | Abandon | 58 | 2 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner JONES-FOSTER, ERICA NICOLE works in Art Unit 1656 and has examined 47 patent applications in our dataset. With an allowance rate of 38.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner JONES-FOSTER, ERICA NICOLE's allowance rate of 38.3% places them in the 7% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by JONES-FOSTER, ERICA NICOLE receive 1.85 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by JONES-FOSTER, ERICA NICOLE is 47 months. This places the examiner in the 9% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +39.1% benefit to allowance rate for applications examined by JONES-FOSTER, ERICA NICOLE. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 21.4% of applications are subsequently allowed. This success rate is in the 25% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 38.9% of cases where such amendments are filed. This entry rate is in the 59% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 98% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.